Opportunities and challenges of pluripotent stem cell neurodegenerative disease models

Sandoe, Jackson; Eggan, Kevin
July 2013
Nature Neuroscience;Jul2013, Vol. 16 Issue 7, p780
Academic Journal
Human neurodegenerative disorders are among the most difficult to study. In particular, the inability to readily obtain the faulty cell types most relevant to these diseases has impeded progress for decades. Recent advances in pluripotent stem cell technology now grant access to substantial quantities of disease-pertinent neurons both with and without predisposing mutations. While this suite of technologies has revolutionized the field of 'in vitro disease modeling', great care must be taken in their deployment if robust, durable discoveries are to be made. Here we review what we perceive to be several of the stumbling blocks in the use of stem cells for the study of neurological disease and offer strategies to overcome them.


Related Articles

  • Gene Reprogramming Has Become Possible.  // USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p7 

    The article focuses on a study by scientists from the Morganridge Institute for Research at the University of Wisconsin which shows that potentially cancer-causing mutations in induced pluripotent stem cells (IPSCs) do not exhibit substantial increases during gene reprogramming.

  • Stem Cell Mutations Explored. Luntz, Stephen // Australasian Science;Mar2012, Vol. 33 Issue 2, p5 

    The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.

  • The individuality of stem cells. Lander, Arthur D. // BMC Biology;2011, Vol. 9 Issue 1, p40 

    In this article the author comments on the uniqueness of stem cells. He states that stem cells are considered to be different from other cells because of properties like immortality, pluripotency and asymmetric division. However, such properties are not common in all stem cells and can be seen...

  • Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities. Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Shibata, Darryl; Zitting, Madison; Chow, Robert H.; Moser, Ann B.; Steinberg, Steven J.; Hacia, Joseph G. // Stem Cell Research & Therapy;Aug2015, Vol. 6 Issue 1, p1 

    Introduction: Zellweger spectrum disorder (PBD-ZSD) is a disease continuum caused by mutations in a subset of PEX genes required for normal peroxisome assembly and function. They highlight the importance of peroxisomes in the development and functions of the central nervous system, liver, and...

  • Unexpected mutations put stem cell trial on hold. Coghlan, Andy // New Scientist;8/8/2015, Vol. 227 Issue 3033, p9 

    The article reports that a stem-cell trial using induced pluripotent stem cells has been halted after mutations were found in the cells of a participant, including a mutation that could carry a remote cancer risk, and mentions the trial turned skin cells into retinal cells to try and reverse...

  • Induced pluripotent stem cells and promises of neuroregenerative medicine. Verma, Ashok; Verma, Nipun // Neurology India;Jul2011, Vol. 59 Issue 4, p555 

    First created in 2006 from adult somatic cells by a simple molecular genetic trick, induced pluripotent stem cells (iPS) system is the latest platform in stem cell research. Induced pluripotent stem cells are produced by nuclear reprogramming technology and they resemble embryonic stem cells...

  • Alzheimer's Neurons Induced from Pluripotent Stem Cells.  // Bioscience Technology;Feb2012, Vol. 36 Issue 2, p13 

    The article reports that scientists led by researchers at the University of California, San Diego School of Medicine have created stem cell-derived in vitro models of sporadic and hereditary Alzheimer's disease using induced pluripotent stem cells from patients with the neurodegenerative disorder.

  • Neurogenic differentiation of amniotic fluid stem cells. Rosner, M.; Mikula, M.; Preitschopf, A.; Feichtinger, M.; Schipany, K.; Hengstschläger, M. // Amino Acids;May2012, Vol. 42 Issue 5, p1591 

    In 2003, human amniotic fluid has been shown to contain stem cells expressing Oct-4, a marker for pluripotency. This finding initiated a rapidly growing and very promising new stem cell research field. Since then, amniotic fluid stem (AFS) cells have been demonstrated to harbour the potential to...

  • Patient-Specific Naturally Gene-Reverted Induced Pluripotent Stem Cells in Recessive Dystrophic Epidermolysis Bullosa. Tolar, Jakub; McGrath, John A; Xia, Lily; Riddle, Megan J; Lees, Chris J; Eide, Cindy; Keene, Douglas R; Liu, Lu; Osborn, Mark J; Lund, Troy C; Blazar, Bruce R; Wagner, John E // Journal of Investigative Dermatology;May2014, Vol. 134 Issue 5, p1246 

    Spontaneous reversion of disease-causing mutations has been observed in some genetic disorders. In our clinical observations of severe generalized recessive dystrophic epidermolysis bullosa (RDEB), a currently incurable blistering genodermatosis caused by loss-of-function mutations in COL7A1...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics